参考文献/References:
[1] Stiles ZE, Glazer ES, Deneve JL, et al. Long-term implications of unplanned conversion during laparoscopic liver resection for hepatocellular carcinoma[J]. Ann Surg Oncol, 2019, 26: 282-289.
[2] Xu Y, Shen Q, Liu P, et al. Microwave ablation for the treatment of hepatocellular carcinoma that met up-to-seven criteria: feasibility， local efficacy and long-term outcomes[J]. Eur Radiol, 2017, 27: 3877-3887.
[3] Lazuardi F, Valencia J, Zheng S. Adjuvant transcatheter arterial chemoembolization after radical resection of hepatocellular carcinoma patients with tumor size less than 5 cm: a retrospective study[J]. Scand J Gastroenterol, 2019, 54: 617-622.
[4] 罗?君， 邵国良， 郑家平， 等. 原发性肝癌肝动脉化疗栓塞术后腹痛的发生规律及影响因素[J]. 介入放射学杂志， 2017， 26：613-617.
[5] Liu S, Guo L, Li H, et al. Postoperative adjuvant trans-arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus[J]. Ann Surg Oncol, 2018, 25: 2098-2104.
[6] De Baere T, Arai Y, Lencioni R, et al. Treatment of liver tumors with lipiodol TACE: technical recommendations from experts opinion[J]. Cardiovasc Intervent Radiol, 2016, 39: 334-343.
[7] Khalaf MH, Sundaram V, Abdelrazek MM, et al. A predictive model for postembolization syndrome after transarterial hepatic chemoembolization of hepatocellular carcinoma[J]. Radiology, 2019, 290: 254-261.
[8] Lü N, Kong Y, Mu L, et al. Effect of perioperative parecoxib Sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial[J]. Eur Radiol, 2016, 26: 3492-3499.
[9] Pleguezuelos-Villa M, Nacher A， Hernandez MJ, et al. A novel lidocaine hydrochloride mucoadhesive films for periodontal diseases[J]. J Mater Sci Mater Med, 2019, 30: 14.
[10] Lee SH, Hahn ST, Park SH. Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration[J]. Cardiovasc Intervent Radiol, 2002, 24: 368-371.
[11] Nebbioso M, Livani ML, Santamaria V, et al. Intracameral lidocaine as supplement to classic topical anesthesia for relieving ocular pain in cataract surgery[J]. Int J Ophthalmol, 2018, 11: 1932-1935.
[12] 文?军， 刘?丽， 徐向贤， 等. 雷替曲塞经TACE治疗原发性肝癌的临床疗效分析[J]. 介入放射学杂志， 2019， 28：175-178.
[13] Yang H, Seon J, Sung PS, et al. Dexamethasone prophylaxis to alleviate postembolization syndrome after transarterial chemoembolization for hepatocellular carcinoma: a randomized, double-blinded, placebo-controlled study[J]. J Vasc Interv Radiol, 2017, 28: 1503-1511.
[14] Blackburn H, West S. Management of postembolization syndrome following hepatic transarterial chemoembolization for primary or metastatic liver cancer[J]. Cancer Nurs, 2016, 39: E1-E18.
[15] Feng YL, Ling CQ, Zhai XF, et al. A new way: alleviating postembolization syndrome following transcatheter arterial chemoembolization[J]. J Altern Complement Med, 2009, 15: 175-181.
[16] Xu L, Wang S, Zhuang L, et al. Jian Pi Li Qi decoction alleviated postembolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma[J]. Integr Cancer Ther, 2016, 15: 349-357.
[17] Yang L, Zhang XM, Zhou XP, et al. Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization[J]. J Vasc Interv Radiol, 2010, 21: 1841-1846.
[18] Setnik B, Sommerville K, Goli V, et al. Assessment of pharmacodynamic effects following oral administration of crushed morphine sulfate and naltrexone hydrochloride extended-release capsules compared with crushed morphine sulfate controlled-release tablets and placebo in nondependent recreational opioid users[J]. Pain Med, 2013, 14: 1173-1186.
[19] Guo JG, Zhao LP, Rao YF, et al. Novel multimodal analgesia regimen improves post-TACE pain in patients with hepatocellular carcinoma[J]. Hepatobiliary Pancreat Dis Int, 2018, 17: 510-516.
[20] Wang ZX, Li L, Tao FY. Health education helps to relieve postembolization pain during hepatic arteria chemoembolization therapy[J]. J Pain Res, 2018, 11: 2115-2121.
相似文献/References:
[1]杨永波,程红岩.肝动脉化疗栓塞治疗中碘油用量的现状与研究进展[J].介入放射学杂志,2012,(04):348.
.Ｔｈｅ ｖｏｌｕｍｅ ｏｆ Ｌｉｐｉｏｄｏｌ ｕｓｅｄ ｉｎ ＴＡＣＥ： ｉｔｓ ｃｕｒｒｅｎｔ ｓｉｔｕａｔｉｏｎ ａｎｄ ｒｅｓｅａｒｃｈ ｐｒｏｇｒｅｓｓ [J].journal interventional radiology,2012,(04):348.
[2]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗３０例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
,,et al.ＴＡＣＥ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ｒａｄｉｏｆｒｅｑｕｅｎｃｙ ａｂｌａｔｉｏｎ ｆｏｒ ｍａｓｓｉｖｅ ｐｒｉｍａｒｙ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ａ ｃｌｉｎｉｃａｌ ｔｈｅｒａｐｅｕｔｉｃ ｅｖａｌｕａｔｉｏｎ [J].journal interventional radiology,2012,(04):322.
[3]张 磊,陆骊工,李 勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,(12):968.
ZHANG Lei,LU Li-gong,LI Yong,et al.Portal vein stent placement combined with TACE for the treatment of hepatocellular carcinoma associated with tumor thrombus in portal vein[J].journal interventional radiology,2011,(04):968.
[4]敖 劲,张跃伟,徐 克. 明胶海绵微粒经动脉栓塞治疗原发性肝癌的研究现状[J].介入放射学杂志,2011,(12):1010.
AO Jin,ZHANG Yue-wei,XU Ke..Gelatin sponge particle used as an embolic agent in transcatheter arterial chemoembolization treatment for primary hepatocellular carcinoma: its current situation in research[J].journal interventional radiology,2011,(04):1010.
[5]杜丹丹,吕维富. 肝癌射频消融后的影像学评价[J].介入放射学杂志,2012,(01):75.
DU Dan dan,Lv Wei fu..Imaging evaluation of liver cancer after radiofrequency ablation therapy[J].journal interventional radiology,2012,(04):75.
[6]赵 艳,韩国宏,白 苇,等. 药物缓释微球肝动脉化疗栓塞治疗肝癌研究进展[J].介入放射学杂志,2012,(01):78.
ZHAO Yan,HAN Guo-hong,BAI Wei,et al.Transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma: its research progress[J].journal interventional radiology,2012,(04):78.
[7]何海涛,刘 圣,刘建秦,等. 肝癌TACE术并发脑碘油栓塞二例并文献复习[J].介入放射学杂志,2012,(08):682.
HE Hai- tao,LIU sheng,LIU Jian- qing,et al. Cerebral Lipiodol embolism occurred after transcatheter arterial chemoembolization for hepatocellular carcinoma: report of two cases with literature review[J].journal interventional radiology,2012,(04):682.
[8]罗中华,秦 勉,张学昕,等.原发性肝癌合并下腔静脉及右心房癌栓的动脉内化疗栓塞治疗[J].介入放射学杂志,2012,(12):1035.
LUO Zhong? hua,QIN Mian,ZHANG Xue? xin,et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma complicated by tumor thrombus in inferior vena cava and right atrium[J].journal interventional radiology,2012,(04):1035.
[9]徐 阳,臧 爽,陈路锋,等.Logistic回归及ROC曲线综合评价血生化指标对肝癌TACE术后发热的预测价值 [J].介入放射学杂志,2013,(06):513.
XU Yang,ZANG Shuang,CHEN Lu? feng,et al. Combination evaluation of plasma biochemical indexes with Logistic regression and ROC analysis in predicting hyperthermia after transcatheter hepatic arterial chemoembolization for liver cancer[J].journal interventional radiology,2013,(04):513.
[10]彭国文,李晓群. 射频消融及组合方案治疗特殊/高危部位肝癌的中远期疗效[J].介入放射学杂志,2013,(06):525.
PENG Guo? wen,LI Xiao? qun.. The mid?蛳 to?蛳 long term efficacy of radiofrequency ablation together with combination regimen for the treatment of hepatic carcinomas located at special or high?蛳 risk regions[J].journal interventional radiology,2013,(04):525.